Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy

  • Schmalz, Gerhard (Department of Cariology, Endodontology and Periodontology, University Leipzig) ;
  • Kummer, Max Kristian (Department of Cariology, Endodontology and Periodontology, University Leipzig) ;
  • Kottmann, Tanja (Clinical Research Organization (CRO)) ;
  • Rinke, Sven (Dental Practice, Hanau & Alzenau) ;
  • Haak, Rainer (Department of Cariology, Endodontology and Periodontology, University Leipzig) ;
  • Krause, Felix (Department of Cariology, Endodontology and Periodontology, University Leipzig) ;
  • Schmidt, Jana (Department of Cariology, Endodontology and Periodontology, University Leipzig) ;
  • Ziebolz, Dirk (Department of Cariology, Endodontology and Periodontology, University Leipzig)
  • Received : 2018.06.07
  • Accepted : 2018.08.20
  • Published : 2018.08.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: The aim of this retrospective cross-sectional study was to evaluate whether salivary findings of active matrix-metalloproteinase 8 (aMMP-8) chairside (point of care; POC) tests were associated with periodontal risk assessment parameters in patients receiving supportive periodontal therapy (SPT). Methods: A total of 125 patients receiving regular SPT were included, and their records were examined. The following inclusion criteria were used: a diagnosis of chronic periodontitis, at least 1 non-surgical periodontal treatment (scaling and root planning) with following regular SPT (minimum once a year), at least 6 remaining teeth, and clinical and aMMP-8 findings that were obtained at the same appointment. In addition to anamnestic factors (e.g., smoking and diabetes), oral hygiene indices (modified sulcus bleeding index [mSBI] and approximal plaque index), periodontal probing depth simultaneously with bleeding on probing, and dental findings (number of decayed, missing, and filled teeth) were recorded. Salivary aMMP-8 levels were tested using a commercial POC test system (Periomarker, Hager & Werken, Duisburg, Germany). Statistical analysis was performed using the t-test, Mann-Whitney U test, Fisher's exact test, and ${\chi}^2$ test, as appropriate (P<0.05). Results: Only the mSBI was significantly associated with positive salivary aMMP-8 findings (aMMP-8 positive: $27.8%{\pm}20.9%$ vs. aMMP-8 negative: $18.0%{\pm}14.5%$; P=0.017). No significant associations were found between aMMP-8 and smoking, diabetes, periodontal parameters, or parameters related to the maintenance interval (P>0.05). Conclusions: Salivary aMMP-8 chairside findings were not associated with common parameters used for periodontal risk assessment in patients receiving SPT. The diagnostic benefit of POC salivary aMMP-8 testing in risk assessment and maintenance interval adjustment during SPT remains unclear.

Keywords

References

  1. Frencken JE, Sharma P, Stenhouse L, Green D, Laverty D, Dietrich T. Global epidemiology of dental caries and severe periodontitis - a comprehensive review. J Clin Periodontol 2017;44 Suppl 18:S94-105. https://doi.org/10.1111/jcpe.12677
  2. Jordan RA, Micheelis W. The fifth German oral health study (DMS V). Koln: Institut der Deutschen Zahnarzte; 2016. [in German]
  3. Renvert S, Persson GR. Supportive periodontal therapy. Periodontol 2000 2004;36:179-95. https://doi.org/10.1111/j.1600-0757.2004.03680.x
  4. Lee CT, Huang HY, Sun TC, Karimbux N. Impact of patient compliance on tooth loss during supportive periodontal therapy: a systematic review and meta-analysis. J Dent Res 2015;94:777-86. https://doi.org/10.1177/0022034515578910
  5. Armitage GC, Xenoudi P. Post-treatment supportive care for the natural dentition and dental implants. Periodontol 2000 2016;71:164-84. https://doi.org/10.1111/prd.12122
  6. Farooqi OA, Wehler CJ, Gibson G, Jurasic MM, Jones JA. Appropriate recall interval for periodontal maintenance: a systematic review. J Evid Based Dent Pract 2015;15:171-81. https://doi.org/10.1016/j.jebdp.2015.10.001
  7. Lang NP, Tonetti MS. Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health Prev Dent 2003;1:7-16.
  8. Costa FO, Cota LO, Lages EJ, Lima Oliveira AP, Cortelli SC, Cortelli JR, et al. Periodontal risk assessment model in a sample of regular and irregular compliers under maintenance therapy: a 3-year prospective study. J Periodontol 2012;83:292-300. https://doi.org/10.1902/jop.2011.110187
  9. Lang NP, Tonetti MS. Periodontal diagnosis in treated periodontitis. Why, when and how to use clinical parameters. J Clin Periodontol 1996;23:240-50. https://doi.org/10.1111/j.1600-051X.1996.tb02083.x
  10. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-21. https://doi.org/10.1080/07853890600800103
  11. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-8. https://doi.org/10.1111/j.1601-0825.2004.01038.x
  12. Golub LM, Payne JB, Reinhardt RA, Nieman G. Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical "two-hit" model. J Dent Res 2006;85:102-5. https://doi.org/10.1177/154405910608500201
  13. Kraft-Neumarker M, Lorenz K, Koch R, Hoffmann T, Mantyla P, Sorsa T, et al. Full-mouth profile of active MMP-8 in periodontitis patients. J Periodontal Res 2012;47:121-8. https://doi.org/10.1111/j.1600-0765.2011.01416.x
  14. Soder B, Jin LJ, Wickholm S. Granulocyte elastase, matrix metalloproteinase-8 and prostaglandin E2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-91. https://doi.org/10.1034/j.1600-051X.2002.290502.x
  15. Mantyla P, Stenman M, Kinane D, Salo T, Suomalainen K, Tikanoja S, et al. Monitoring periodontal disease status in smokers and nonsmokers using a gingival crevicular fluid matrix metalloproteinase-8-specific chair-side test. J Periodontal Res 2006;41:503-12. https://doi.org/10.1111/j.1600-0765.2006.00897.x
  16. Sorsa T, Tervahartiala T, Leppilahti J, Hernandez M, Gamonal J, Tuomainen AM, et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011;63:108-13. https://doi.org/10.1016/j.phrs.2010.10.005
  17. Zhang L, Li X, Yan H, Huang L. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e9642. https://doi.org/10.1097/MD.0000000000009642
  18. Izadi Borujeni S, Mayer M, Eickholz P. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case-control study. Med Microbiol Immunol (Berl) 2015;204:665-72. https://doi.org/10.1007/s00430-015-0413-2
  19. Heikkinen AM, Nwhator SO, Rathnayake N, Mantyla P, Vatanen P, Sorsa T. Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents. J Periodontol 2016;87:36-40. https://doi.org/10.1902/jop.2015.150377
  20. Schmidt J, Guder U, Kreuz M, Loffler M, Kiess W, Hirsch C, et al. aMMP-8 in correlation to caries and periodontal condition in adolescents-results of the epidemiologic LIFE child study. Clin Oral Investig 2018;22:449-60. https://doi.org/10.1007/s00784-017-2132-0
  21. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6. https://doi.org/10.1902/annals.1999.4.1.1
  22. World Health Organization. Oral health surveys: basic methods. 4th ed. Geneva: World Health Organization; 1997.
  23. Muhlemann HR, Son S. Gingival sulcus bleeding--a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-13.
  24. Lange DE, Plagmann HC, Eenboom A, Promesberger A. Clinical methods for the objective evaluation of oral hygiene. Dtsch Zahnarztl Z 1977;32:44-7.
  25. Sorsa T, Gursoy UK, Nwhator S, Hernandez M, Tervahartiala T, Leppilahti J, et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000 2016;70:142-63. https://doi.org/10.1111/prd.12101
  26. Lorenz K, Keller T, Noack B, Freitag A, Netuschil L, Hoffmann T. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8: agreement between qualitative and quantitative measurements and relation to periodontal inflammation. J Periodontal Res 2017;52:277-84. https://doi.org/10.1111/jre.12392
  27. Rathnayake N, Gieselmann DR, Heikkinen AM, Tervahartiala T, Sorsa T. Salivary diagnostics-point-of-care diagnostics of MMP-8 in dentistry and medicine. Diagnostics (Basel) 2017;7:7. https://doi.org/10.3390/diagnostics7010007
  28. Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-46. https://doi.org/10.1902/jop.2009.080480
  29. Mantyla P, Stenman M, Kinane DF, Tikanoja S, Luoto H, Salo T, et al. Gingival crevicular fluid collagenase-2 (matrix metalloproteinase-8) test stick for chair-side monitoring of periodontitis. J Periodontal Res 2003;38:436-9. https://doi.org/10.1034/j.1600-0765.2003.00677.x
  30. Mullins JM, Even JB, White JM. Periodontal management by risk assessment: a pragmatic approach. J Evid Based Dent Pract 2016;16 Suppl:91-8. https://doi.org/10.1016/j.jebdp.2016.01.020
  31. Lyle DM. Risk assessment a key to periodontal health promotion and disease prevention. Compend Contin Educ Dent 2014;35:392-6.
  32. Lang NP, Suvan JE, Tonetti MS. Risk factor assessment tools for the prevention of periodontitis progression a systematic review. J Clin Periodontol 2015;42 Suppl 16:S59-70. https://doi.org/10.1111/jcpe.12350
  33. Ito H, Numabe Y, Sekino S, Murakashi E, Iguchi H, Hashimoto S, et al. Evaluation of bleeding on probing and gingival crevicular fluid enzyme activity for detection of periodontally active sites during supportive periodontal therapy. Odontology 2014;102:50-6. https://doi.org/10.1007/s10266-012-0090-1
  34. Sorsa T, Mantyla P, Tervahartiala T, Pussinen PJ, Gamonal J, Hernandez M. Matrix metalloproteinase activation in diagnostics of periodontitis and systemic inflammation. J Clin Periodontol 2011;38:817-9. https://doi.org/10.1111/j.1600-051X.2011.01753.x
  35. Hernandez M, Dutzan N, Garcia-Sesnich J, Abusleme L, Dezerega A, Silva N, et al. Host-pathogen interactions in progressive chronic periodontitis. J Dent Res 2011;90:1164-70. https://doi.org/10.1177/0022034511401405
  36. Rai B, Kharb S, Jain R, Anand SC. Biomarkers of periodontitis in oral fluids. J Oral Sci 2008;50:53-6. https://doi.org/10.2334/josnusd.50.53

Cited by

  1. Changing the Focus to the Whole Patient instead of One Oral Disease: The Concept of Individualized Prevention vol.2020, pp.None, 2020, https://doi.org/10.1155/2020/6752342
  2. Diagnostic Models for Screening of Periodontitis with Inflammatory Mediators and Microbial Profiles in Saliva vol.10, pp.10, 2020, https://doi.org/10.3390/diagnostics10100820
  3. Diagnostic ability of salivary matrix metalloproteinase‐9 lateral flow test point‐of‐care test for periodontitis vol.47, pp.11, 2018, https://doi.org/10.1111/jcpe.13360
  4. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic vol.18, pp.8, 2018, https://doi.org/10.1080/14789450.2021.1976151
  5. On the accuracy, sensitivity, and grading of mouthrinse active matrix metalloproteinase‐8 (aMMP‐8) point‐of‐care testing (POCT) vol.48, pp.11, 2021, https://doi.org/10.1111/jcpe.13521